6533b86dfe1ef96bd12ca7e2

RESEARCH PRODUCT

An Analysis of “No Effect of Insulin Pen with Memory Function on Glycemic Control in a Patient Cohort with Poorly Controlled Type 1 Diabetes: A Randomized Open-Label Study”

Francisco Javier Ampudia-blasco

subject

Type 1 diabetesPediatricsmedicine.medical_specialtyAdult patientsbusiness.industryEndocrinology Diabetes and MetabolismBiomedical EngineeringInsulin penBioengineeringmedicine.diseaseBolus (medicine)Open label studyDiabetes mellitusCohortInternal MedicinemedicineIntensive care medicinebusinessGlycemic

description

Missing meal bolus and nonadherence is an important barrier to achieving glycemic goals in type 1 diabetes (T1DM). In this issue of Journal of Diabetes Science and Technology, Danne and coauthors reported the results of a 24-week randomized-controlled study designed to evaluate if using an insulin pen with memory function, the HumaPen® Memoir™, might improve injection compliance and, therefore, overall glycemic control in T1DM. Patients treated with the pen device with memory function improved, albeit nonsignificantly, their mean HbA1c by 0.43%. Among the reasons to justify why this study was not positive, the most important is the high proportion of adult patients included in the study (87.9%)—children and adolescents being under-represented. I am convinced that pen devices with memory function might be helpful for forgetful patients (children, adolescents), as suggested in another recent study.

https://doi.org/10.1177/193229681200600620